Published in Trans R Soc Trop Med Hyg on December 28, 1993
Polymorphism in tumor necrosis factor genes associated with mucocutaneous leishmaniasis. J Exp Med (1995) 2.30
A recombinant Leishmania antigen that stimulates human peripheral blood mononuclear cells to express a Th1-type cytokine profile and to produce interleukin 12. J Exp Med (1995) 1.81
Impaired expression of inflammatory cytokines and chemokines at early stages of infection with Leishmania amazonensis. Infect Immun (2003) 1.74
Immune responses of leishmaniasis patients to heat shock proteins of Leishmania species and humans. Infect Immun (1995) 1.20
Concurrent Chagas' disease and borderline disseminated cutaneous leishmaniasis: The role of amiodarone as an antitrypanosomatidae drug. Ther Clin Risk Manag (2008) 1.02
Successful therapy of chronic, nonhealing murine cutaneous leishmaniasis with sodium stibogluconate and gamma interferon depends on continued interleukin-12 production. Infect Immun (1997) 0.97
T-bet, GATA-3, and Foxp3 expression and Th1/Th2 cytokine production in the clinical outcome of human infection with Leishmania (Viannia) species. J Infect Dis (2010) 0.96
Tamoxifen is effective in the treatment of Leishmania amazonensis infections in mice. PLoS Negl Trop Dis (2008) 0.95
Testing of four Leishmania vaccine candidates in a mouse model of infection with Leishmania (Viannia) braziliensis, the main causative agent of cutaneous leishmaniasis in the New World. Clin Vaccine Immunol (2007) 0.92
Differing antibody IgG isotypes in the polar forms of leprosy and cutaneous leishmaniasis characterized by antigen-specific T cell anergy. Clin Exp Immunol (1995) 0.90
Exposure of phosphatidylserine on Leishmania amazonensis isolates is associated with diffuse cutaneous leishmaniasis and parasite infectivity. PLoS One (2012) 0.88
Immunoblot analysis of Leishmania panamensis antigens in sera of patients with American cutaneous leishmaniasis. J Clin Microbiol (1997) 0.87
Serodiagnosis of anthroponotic cutaneous leishmaniasis (ACL) caused by Leishmania tropica in Sanliurfa Province, Turkey, where ACL Is highly endemic. Clin Vaccine Immunol (2007) 0.87
Endogenous interleukin-12 is critical for controlling the late but not the early stage of Leishmania mexicana infection in C57BL/6 mice. Infect Immun (2002) 0.86
Association of Leishmania heat shock protein 83 antigen and immunoglobulin G4 antibody titers in Brazilian patients with diffuse cutaneous leishmaniasis. Infect Immun (1997) 0.83
In vitro responses of human peripheral blood mononuclear cells to whole-cell, particulate and soluble extracts of Leishmania promastigotes. Clin Exp Immunol (2006) 0.83
Leishmania tropica infection, in comparison to Leishmania major, induces lower delayed type hypersensitivity in BALB/c mice. Korean J Parasitol (2007) 0.82
The Role of CD4 and CD8 T Cells in Human Cutaneous Leishmaniasis. Front Public Health (2014) 0.82
Apoptosis and frequency of total and effector CD8+ T lymphocytes from cutaneous leishmaniasis patients during antimonial therapy. BMC Infect Dis (2015) 0.81
Subversion of Immunity by Leishmania amazonensis Parasites: Possible Role of Phosphatidylserine as a Main Regulator. J Parasitol Res (2012) 0.80
Enhancement of a TH1 immune response in amphotericin B-treated mucocutaneous leishmaniasis. J Biomed Biotechnol (2007) 0.80
In vitro metacyclogenesis of Leishmania (Viannia) braziliensis and Leishmania (Leishmania) amazonensis clinical field isolates, as evaluated by morphology, complement resistance, and infectivity to human macrophages. Biomed Res Int (2015) 0.80
Visceral leishmaniasis in a patient with cutaneous lesions, negative Leishman-Donovan bodies and immunological test: A case report. J Res Med Sci (2011) 0.80
Characterization of chronic cutaneous lesions from TNF-receptor-1-deficient mice infected by Leishmania major. Clin Dev Immunol (2011) 0.80
Sphingolipid degradation in Leishmania (Leishmania) amazonensis. PLoS Negl Trop Dis (2012) 0.77
Chemokines and chemokine receptors expression in the lesions of patients with American cutaneous leishmaniasis. Mem Inst Oswaldo Cruz (2013) 0.77
Leishmanicidal activities of novel synthetic furoxan and benzofuroxan derivatives. Antimicrob Agents Chemother (2014) 0.77
Brazilian Amazon Traditional Medicine and the Treatment of Difficult to Heal Leishmaniasis Wounds with Copaifera. Evid Based Complement Alternat Med (2017) 0.75
Diffuse and disseminated cutaneous leishmaniasis: clinical cases experienced in Ecuador and a brief review. Trop Med Health (2016) 0.75
Broadly protective vaccine for Staphylococcus aureus based on an in vivo-expressed antigen. Science (1999) 4.08
Anaerobic conditions induce expression of polysaccharide intercellular adhesin in Staphylococcus aureus and Staphylococcus epidermidis. Infect Immun (2001) 2.72
Mathematical modeling reveals threshold mechanism in CD95-induced apoptosis. J Cell Biol (2004) 2.70
Neuron-specific enolase is produced by neuroendocrine tumours. Lancet (1981) 2.63
Determination of the cytokine profile in American cutaneous leishmaniasis using the polymerase chain reaction. Clin Exp Immunol (1993) 1.88
Characterization of the cellular immune response in American cutaneous leishmaniasis. Clin Immunol Immunopathol (1983) 1.87
Immunoprophylactic trial with combined Mycobacterium leprae/BCG vaccine against leprosy: preliminary results. Lancet (1992) 1.87
Diffuse cutaneous leishmaniasis: a disease due to an immunological defect of the host. Trans R Soc Trop Med Hyg (1972) 1.69
Adherence of Staphylococcus aureus to endothelial cells: influence of capsular polysaccharide, global regulator agr, and bacterial growth phase. Infect Immun (2000) 1.68
[Standardized laparoscopic hernioplasty vs. Shouldice repair. Results of a randomized comparative study]. Chirurg (1995) 1.65
Elimination of Mycobacterium leprae subsequent to local in vivo activation of macrophages in lepromatous leprosy by other mycobacteria. Clin Exp Immunol (1974) 1.54
A randomised study of topical 5% imiquimod vs. topical 5-fluorouracil vs. cryosurgery in immunocompetent patients with actinic keratoses: a comparison of clinical and histological outcomes including 1-year follow-up. Br J Dermatol (2007) 1.42
Immunotherapy with a mixture of Mycobacterium leprae and BCG in different forms of leprosy and in Mitsuda-negative contacts. Int J Lepr Other Mycobact Dis (1982) 1.41
Mechanisms associated with immunoregulation in human American cutaneous leishmaniasis. Clin Exp Immunol (1984) 1.40
Prevention of non-melanoma skin cancer in organ transplant patients by regular use of a sunscreen: a 24 months, prospective, case-control study. Br J Dermatol (2009) 1.28
Immunological changes observed in indeterminate and lepromatous leprosy patients and Mitsuda-negative contacts after the inoculation of a mixture of Mycobacterium leprae and BCG. Clin Exp Immunol (1979) 1.26
Immunotherapy versus chemotherapy in localised cutaneous leishmaniasis. Lancet (1987) 1.24
A novel cytokinin-resistant mutant of Arabidopsis with abbreviated shoot development. Planta (1995) 1.18
Total gastrectomy. Updated operative mortality and long-term survival with particular reference to patients older than 70 years of age. Ann Surg (1996) 1.15
Lymphocyte transformation with phytomitogens in leprosy. Int J Lepr Other Mycobact Dis (1972) 1.15
In situ characterization of the cellular immune response in American cutaneous leishmaniasis. Clin Exp Immunol (1985) 1.13
Diffuse cutaneous leishmaniasis responds to miltefosine but then relapses. Br J Dermatol (2007) 1.13
The influence of folic acid supplement on the outcome of pregnancies in the county of Funen in Denmark. Part I. Eur J Obstet Gynecol Reprod Biol (1999) 1.11
Double immunogold staining method for the simultaneous ultrastructural localization of regulatory peptides. J Histochem Cytochem (1983) 1.05
Production of monoclonal mouse IgE antibodies with DNP specificity by hybrid cell lines. Int Arch Allergy Appl Immunol (1980) 1.05
Vaccine potential of poly-1-6 beta-D-N-succinylglucosamine, an immunoprotective surface polysaccharide of Staphylococcus aureus and Staphylococcus epidermidis. J Biotechnol (2000) 1.05
Recurrence after endoscopic transperitoneal hernia repair (TAPP): causes, reparative techniques, and results of the reoperation. J Am Coll Surg (2000) 1.04
Immunotherapy of american cutaneous leishmaniasis in Venezuela during the period 1990-99. Trans R Soc Trop Med Hyg (2004) 1.03
Distribution of bacteria in the epidermal layers and hair follicles of the human skin. Skin Pharmacol Physiol (2011) 1.03
Generation of Pseudomonas aeruginosa aerosols during handwashing from contaminated sink drains, transmission to hands of hospital personnel, and its prevention by use of a new heating device. Zentralbl Hyg Umweltmed (1991) 1.01
Trefoil factor family domain peptides in the human respiratory tract. J Pathol (2000) 1.01
Immunotherapy of localized, intermediate, and diffuse forms of American cutaneous leishmaniasis. J Infect Dis (1989) 0.99
Laparoscopic hernia repair--TAPP or/and TEP? Langenbecks Arch Surg (2005) 0.98
T cell-mediated terminal maturation of dendritic cells: loss of adhesive and phagocytotic capacities. J Immunol (1996) 0.97
Scrotal hernias: a contraindication for an endoscopic procedure? Results of a single-institution experience in transabdominal preperitoneal repair. Surg Endosc (2000) 0.97
Vaccination in leprosy--observations and interpretations. Int J Lepr Other Mycobact Dis (1980) 0.96
Cryptosporidiosis in Venezuelan children with acute diarrhea. Am J Trop Med Hyg (1985) 0.94
Atypical cutaneous leishmaniasis in Central America: possible interaction between infectious and environmental elements. Trans R Soc Trop Med Hyg (2005) 0.93
Intermediate or chronic cutaneous leishmaniasis: leukocyte immunophenotypes and cytokine characterisation of the lesion. Exp Dermatol (2002) 0.93
Immunogold staining procedure for the localisation of regulatory peptides. Peptides (1982) 0.92
The IgG isotypes of specific antibodies in patients with American cutaneous leishmaniasis; relationship to the cell-mediated immune response. Parasite Immunol (1996) 0.92
BCG vaccination protects against leprosy in Venezuela: a case-control study. Int J Lepr Other Mycobact Dis (1993) 0.92
Chronic lithium and sodium valproate both decrease the concentration of myo-inositol and increase the concentration of inositol monophosphates in rat brain. Brain Res (2000) 0.91
The anastomosis angle does change the flow fields at vascular end-to-side anastomoses in vivo. J Vasc Surg (1995) 0.91
The development of a vaccination model using two microorganisms and its application in leprosy and leishmaniasis. Lepr Rev (1986) 0.91
Canine visceral leishmaniasis on Margarita Island (Nueva Esparta, Venezuela). Trans R Soc Trop Med Hyg (2000) 0.90
TAPP - Stuttgart technique and result of a large single center series. J Minim Access Surg (2006) 0.90
Trypanosoma cruzi and American Leishmania spp: immunocytochemical localization of a laminin-like protein in the plasma membrane. Exp Parasitol (1986) 0.90
Neuron-specific enolase in the Merkel cells of mammalian skin. The use of specific antibody as a simple and reliable histologic marker. Am J Pathol (1981) 0.89
Human monocyte-derived dendritic cells expressing both chemotactic cytokines IL-8, MCP-1, RANTES and their receptors, and their selective migration to these chemokines. Chin Med J (Engl) (2000) 0.88
The effect of fresh serum on the leptomonads of Leishmania. I. Preliminary report. Trans R Soc Trop Med Hyg (1968) 0.88
Immunocytochemical characterization of immune cells in lesions of American cutaneous leishmaniasis using novel T cell markers. Acta Trop (1991) 0.87
Effects of chronic lithium and sodium valproate on concentrations of brain amino acids. Eur Neuropsychopharmacol (2003) 0.87
Known and potential new risk factors for skin cancer in European populations: a multicentre case-control study. Br J Dermatol (2012) 0.87
Catalase, myeloperoxidase and hydrogen peroxide in cystic fibrosis. Eur Respir J (1998) 0.87
Assessing physicians' preferences on skin cancer treatment in Europe. Br J Dermatol (2012) 0.87
Analysis of the class-specific immune response to Yersinia enterocolitica virulence-associated antigens in oro-gastrically infected rabbits. Microb Pathog (1988) 0.87
Erythema dyschromicum perstans. Int J Dermatol (1989) 0.86
Enumeration of selected leukocytes in the small intestine of BALB/c mice infected with Cryptosporidium parvum. Am J Trop Med Hyg (1994) 0.86
Recent advances in the immunology of leprosy. Int J Dermatol (1976) 0.85
Risk factors for actinic keratosis in eight European centres: a case-control study. Br J Dermatol (2012) 0.85
Inadequate epidermal homing leads to tissue damage in human cutaneous leishmaniasis. Immunol Today (1994) 0.85
Possible role of macrophage-like suppressor cells in the anti-tumour activity of BCG. Br J Cancer (1981) 0.85
Notch signaling is not essential in sonic hedgehog-activated medulloblastoma. Oncogene (2010) 0.85
Immunological reactions in onchocerciasis. Trans R Soc Trop Med Hyg (1970) 0.85
Epidemiologic aspects of American visceral leishmaniasis in an endemic focus in Eastern Venezuela. Am J Trop Med Hyg (1999) 0.85
Evaluation of Bowen disease by in vivo reflectance confocal microscopy. Br J Dermatol (2011) 0.84
Nitric oxide and cellular immunity in experimental cutaneous leishmaniasis. Clin Exp Dermatol (2003) 0.84
A study of antibody response in leprosy. Int J Lepr Other Mycobact Dis (1969) 0.84
Inducible nitric oxide synthase and cytokine pattern in lesions of patients with American cutaneous leishmaniasis. Clin Exp Dermatol (2006) 0.83
The effect of human serum DNAases on the ability to detect antibiotic-killed Escherichia coli in blood by PCR. J Med Microbiol (2001) 0.83
Leukocyte immunophenotypes in bronchoalveolar lavage fluid and peripheral blood of paracoccidioidomycosis, sarcoidosis and silicosis. Histol Histopathol (1991) 0.83
Hydrogen peroxide mediates UV-induced impairment of antigen presentation in a murine epidermal-derived dendritic cell line. Photochem Photobiol (1995) 0.83
Soluble intercellular adhesion molecule-1 in cerebrospinal fluid: an indicator for the inflammatory impairment of the blood-cerebrospinal fluid barrier. J Neuroimmunol (1993) 0.83
Mononuclear cell subpopulations and infiltrating lymphocytes in erythema dyschromicum perstans and vitiligo. Histol Histopathol (1987) 0.82
Vaccination of mice with a combination of BCG and killed Leishmania promastigotes reduces acute Trypanosoma cruzi infection by promoting an IFN-gamma response. Vaccine (1999) 0.82
Leishmaniasis: Immunological and clinical aspects and vaccines in Venezuela. Clin Dermatol (1997) 0.82
Immunotherapy and immunoprophylaxis of leprosy. Lepr Rev (1983) 0.82
Isolation of Leishmania infantum, zymodeme MON-1 from canine and human visceral leishmaniasis on Margarita Island, Venezuela. Mem Inst Oswaldo Cruz (2001) 0.82
High voltage electron microscopy of sperm axoneme. J Submicrosc Cytol (1985) 0.81
Bronchial challenge of tropical asthmatics with Ascaris lumbricoides. J Investig Allergol Clin Immunol (1994) 0.81
Interaction of frog virus 3 with the cytomatrix. II. Structure and composition of the virus assembly site. Exp Cell Res (1984) 0.81
Rapid D-dimer testing and pre-test clinical probability in the exclusion of deep venous thrombosis in symptomatic outpatients. Blood Coagul Fibrinolysis (2001) 0.81
Electron immunocytochemical localization of enkephalin-like material in catecholamine-containing cells of the carotid body, the adrenal medulla, and in pheochromocytomas of man and other mammals. J Histochem Cytochem (1982) 0.80
Investigations related to the development of a leprosy vaccine. Int J Lepr Other Mycobact Dis (1983) 0.80
Patient education in community hospitals. Minn Med (1972) 0.80
Adhesion molecules in lesions of American cutaneous leishmaniasis. Exp Dermatol (1994) 0.80
Discovery of a gamma-carboxyglutamic acid-containing protein in human spermatozoa. FEBS Lett (1985) 0.80
Initial clinical experience with an IVUS-guided transmembrane puncture device to facilitate recanalization of total femoral artery occlusions. EuroIntervention (2005) 0.80
Morphologic patterns and diagnostic criteria of VIP-producing endocrine tumors. A histologic, histochemical, ultrastructural, and biochemical study of 32 cases. Cancer (1983) 0.80
Cellular immunity in healthy volunteers treated with an octavalent conjugate Pseudomonas aeruginosa vaccine. Clin Exp Immunol (2006) 0.79
Dermatitis causada por Hylesia metabus (Lepidoptera: Hemileucidae) en la región costera del Estado del Delta del Amacuro, Venezuela [Dermatitis caused by Hylesia metabus (Lepidoptera: Hemileucidae) in the costal region of the state of Delta Amacuro, Venezuela]. Rev Cubana Med Trop (1998) 0.79
Update on non-invasive imaging techniques in early diagnosis of non-melanoma skin cancer. G Ital Dermatol Venereol (2015) 0.79